Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD46, also known as Membrane Cofactor Protein (MCP), is a type I transmembrane glycoprotein that functions as a key regulatory component of the complement system. It is expressed on nearly all nucleated cells (except erythrocytes) and acts as a cofactor for complement factor I-mediated cleavage/inactivation of C3b and C4b, protecting host cells from complement-mediated damage. It also serves as an entry receptor for several pathogens and plays a role in human reproduction and T cell activation. Overexpression is observed in various cancers making it a potential therapeutic target.
Cofactor for complement factor I-mediated cleavage/inactivation of C3b and C4b
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD46 Protein (MCP).